title: [Prostaglandin E1 in the long-term treatment of erectile dysfunction].
abstract: Intravenous injections of Prostaglandin E1 were administered to 65 men suffering from erectile dysfunction. Later on, 59 of them administered the substance to themselves. Our experience as well as literary data have confirmed the efficacy of prostaglandin E1 administered intracavernously in the therapy of different forms of impotence, including the so-called psychogenic form. Its advantage is that it metabolizes directly in the cavernous tissue. Virtually no significant systemic side reactions were recorded and neither priapism nor fibrosis of the corpora cavernosa were observed after long-term treatment. Prostaglandin E1, a product of Léciva Praha, was used within the clinical study of this preparation.
authors.affiliation: Oddelenie reprodukcie a sexuality NsP akad. L. Dérera, Bratislave, CSFR.
authors.forename: J
authors.initials: J
authors.lastname: Vrabec
mesh_terms: D000527:Alprostadil / Q000008:administration & dosage* / Q000009:adverse effects; D007172:Erectile Dysfunction / Q000188:drug therapy*; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D010410:Penile Erection / Q000187:drug effects*; D010413:Penis / Q000098:blood supply
chemical_list: D000527:Alprostadil
vernacular_title: Prostaglandín E1 v dlhodobej liecbe erektilnej dysfunkcie.